DelveInsight Drug Report, “Kivexa- Drug Insights, 2016” highlights the Kivexa marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Kivexa covering the total sales estimation and also provides the Kivexa sales performance during the historical period and forecast period to 2018. DelveInsight’s Report also covers the detailed clinical assessment of Kivexa, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight’s Report provides the SWOT analysis for the Kivexa.
Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug. Scope
A review of the Kivexa based on information derived from company and industry-specific sources Coverage of the Marketed data of the Kivexa on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Kivexa with location details Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Global Forecasted Sales Figure to 2018 Qualitative and quantitative assessment of market space SWOT Analysis Reasons to buy
Evaluate the marketing status and exclusivity details of Kivexa to exploit opportunities for generic drug development opportunities. Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Kivexa. API intelligence over Kivexa and gaining primary intelligence over Active Ingredients manufacturers across the globe. Understanding the chemical route of synthesis of Kivexa. Uncovering opportunities in the rapidly growing the US market Stay ahead of competition by understanding the changing competitive landscape Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential Make more informed business decisions from insightful and in-depth analysis of the drug’s performance Obtain sales forecast for currently marketed drug for to 2018